In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates ...
Nov 23, 2014
0
0
Billions of neurons fire in the brains of stock market traders as they decide whether to buy or sell shares in a matter of seconds. Some of these brain waves produce rational calculations about how best to make a profit, ...
Jul 11, 2014
0
0
If you're so smart, why aren't you rich? It may be that, when it comes to stock market success, your brain is heeding the wrong neural signals.
Jul 7, 2014
2
1
Falling stock prices lead to increased hospitalisations for mental disorders, according to new research published today in the journal Health Policy and Planning.
Feb 13, 2014
0
0
Apricus Biosciences Inc. said Monday that its impotence drug Vitaros has been approved in 10 European countries.
Jun 10, 2013
0
0
Suppose you had $1,000 to invest in the stock market. How would you decide to pick one stock over another? Scientists have made great progress in understanding the neuroscience behind how people choose between similar options.
Apr 19, 2013
0
0
(AP)—Shares of respiratory drug maker KaloBios Pharmaceuticals are inching higher on the first day of trading.
Feb 1, 2013
0
0
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Mar 13, 2012
0
0
